Pinatuzumab vedotin
Jump to navigation
Jump to search
Monoclonal antibody | |
---|---|
Type | ? |
Source | Humanized (from mouse) |
Target | CD22 |
Clinical data | |
Other names | DCDT2980S, FCU2703 |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
Chemical and physical data | |
Formula | C6748H10377N1773O2083S44 |
Molar mass | 151081.21 g·mol−1 |
Pinatuzumab vedotin (INN;[1] development codes DCDT2980S and FCU2703) is a monoclonal antibody designed for the treatment of B-cell malignancies.[2]
This drug was developed by Genentech/Roche.[citation needed]
References
Categories:
- Articles with short description
- Short description is different from Wikidata
- Drugs not assigned an ATC code
- Chemicals that do not have a ChemSpider ID assigned
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drugs that are a monoclonal antibody
- All articles with unsourced statements
- Articles with unsourced statements from February 2023
- All stub articles
- Monoclonal antibody stubs
- Monoclonal antibodies for tumors
- Antibody-drug conjugates
- Experimental cancer drugs